KRAS mutation is one of the most common oncogenic drivers in non-small cell lung cancer (NSCLC), accounting for ~ 25% of Caucasians and ~ 10% of Asians [1, 2]. The gene discussed is KRAS; the disease is non-small cell lung carcinoma.